Oren Gilad

Oren Gilad

Directeur Général chez APREA THERAPEUTICS, INC.

Fortune : 329 335 $ au 31/05/2026

58 ans
Consumer Services
Health Technology

Profil

Oren Gilad was the founder of Atrin Pharmaceuticals LLC, founded in 2011, where the title held was President, Chief Executive Officer & Director.
Dr. Gilad was also the founder of Atrin Pharmaceuticals, Inc., founded in 2011, where the title held was President & Chief Executive Officer from 2011 to 2022.
Currently, Dr. Gilad holds the position of President, Chief Executive Officer & Director at Aprea Therapeutics, Inc., starting in 2022.
The education history includes a doctorate from the University of Pennsylvania, a doctorate from the University of California, Davis, and an undergraduate degree from The Hebrew University of Jerusalem.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
21/04/2026 368 796 ( 2,98 % ) 329 335 $ 31/05/2026

Postes actifs de Oren Gilad

SociétésPosteDébut
APREA THERAPEUTICS, INC. Directeur Général 29/06/2022

Anciens postes connus de Oren Gilad

SociétésPosteFin
Directeur Général 01/01/2022
Fondateur -
Voir l'expérience en détail de Oren Gilad

Formation de Oren Gilad

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés liées

Entreprise privées6

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Oren Gilad
🔇